Experienced in Orbital Pseudotumor

Weihong H. Jiang-Hong

87 Xiangya Road, 
Changsha, CN 
Experienced in Orbital Pseudotumor
87 Xiangya Road, 
Changsha, CN 
OverviewLocationsClinical Research

Overview

Weihong Jiang-Hong practices in Changsha, China. Dr. Jiang-Hong is rated as an Experienced expert by MediFind in the treatment of Orbital Pseudotumor. Their top areas of expertise are Allergic Rhinitis, Nasopharyngeal Carcinoma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Endoscopy, and Nerve Decompression.

Their clinical research consists of co-authoring 254 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Orbital Pseudotumor.

Locations

87 Xiangya Road, Changsha, 410008, China
Other Locations
200 North Zhongshan Road, Nanjing, 210009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Initial Treatment With a Single Capsule Containing Quadruple Combination of Half Doses of Blood Pressure Medicines Versus Standard Dose Dual Therapy in Patients With Hypertension: A Single-center, Randomized, Double-blind, Crossover Trial
Initial Treatment With a Single Capsule Containing Quadruple Combination of Half Doses of Blood Pressure Medicines Versus Standard Dose Dual Therapy in Patients With Hypertension: A Single-center, Randomized, Double-blind, Crossover Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

254 Total Publications

Clinical features, diagnosis and treatment of the nasal cavity and skull base inflammatory myofibroblastic tumor
Clinical features, diagnosis and treatment of the nasal cavity and skull base inflammatory myofibroblastic tumor
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: September 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jiang-Hong's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile